Association of age at pancreatic cancer diagnosis with smoking and drinking: A hospital‐based and meta‐analysis study
Advances in Digestive Medicine · 2026-03 · 13 (1)
DOI: 10.1002/aid2.70024 ↗Abstract
Abstract Recent trends show an alarming rise in pancreatic cancer prevalence among young individuals. Previous studies have presented differences in age at diagnosis. The study aimed to examine the likelihood of a younger age at diagnosis in individuals exposed to known risk factors, compared with those without exposure. We conducted a retrospective cohort analysis of hospitalized patients in Taiwan. The Kaplan–Meier method and a Cox proportional hazards model were used to evaluate survival probabilities and diagnosis risk, respectively. We then performed a systematic review and meta‐analysis to examine the association of the risk of early‐diagnosis pancreatic cancer with smoking and alcohol drinking across different countries. In the cohort of 121 patients with pancreatic cancer, smokers and drinkers were diagnosed at 5.8 and 5.9 years younger than non‐smokers and non‐drinkers, respectively, while those who both smoked and drank were diagnosed 9.7 years earlier. Survival analysis confirmed these findings after adjusting for covariates (smokers: hazard ratio [HR] = 1.75, p = .019; drinkers: HR = 1.78, p = .023), with patients who both smoked and drank having a substantially higher risk of earlier diagnosis (HR = 3.66, 95% confidence interval = 1.97–6.81, p < .001). Meta‐analysis revealed that early smoking initiation (
EUVIMED